Li J, Casteels T, Huber KVM, Lardeau CH, Klughammer J, Farlik M, et al (2017) Artemisinins target GABAA receptor signaling and impair cell identity
He maintained that while the benefits of off-label prescribing can be effective to treat targeted symptoms, one common question within the medical community keeps arising: Is it prudent to jump the line of FDA-approval and essentially bio-hack your way to better health before the science is fully clear? For example, by treating alcoholism with a drug that reduces a sense of reward, satisfaction, perhaps an aspect of joy, and, secondarily, cravings, are we perhaps taking a shortcut and denying the development of other unconscious or conscious processes like stress tolerance, anxiety tolerance, resilience, patience, balance and prudence? Dillon continued
Both medications have shown impressive results in this area
[2] However, like all medications, they come with considerations: They carry an FDA black box warning about a theoretical cancer risk